Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

Fig. 8

Effects of paclitaxel (pac) and cisplatin (cis) on the expression of chemoresistant genes (ERCC1 and TUBB3), and cancer stem cell markers (CD44, Oct4A, CD133 and EpCAM) in OVCAR4 Cont and T2-KD cells. The mRNA and protein expression of a ERCC1 (red) and TUBB3 (green), b CD44 (green), Oct4A (green), CD133 (green) and EpCAM (red), and c P-STAT3 (red) and T-STAT3 (red) in OVCAR4 Cont and T2-KD OVCAR4 cells treated with their respective IC50 doses of cis and pac were determined by immunofluorescence and relative qRT-PCR (untreated cells grey, cis treated red and pac treated, blue). Each experiment was repeated three times and was performed in triplicate. For immunofluorescence images, magnification was (20X); scale bar (in yellow) 20 μM. Significance was determined by one-way ANOVA *p > 0.05; **p > 0.01; ***p > 0.001; ****p < 0.0001 in Cont vs T2-KD cells

Back to article page